Carmen Vigo
About
In The Last Decade
Carmen Vigo
26 papers receiving 823 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 461
- Complementary and alternative medicine 225
- Physiology 146
- Pharmacology 137
- Cellular and Molecular Neuroscience 90
Countries citing papers authored by Carmen Vigo
This map shows the geographic impact of Carmen Vigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Vigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Vigo more than expected).
Fields of papers citing papers by Carmen Vigo
This network shows the impact of papers produced by Carmen Vigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Vigo. The network helps show where Carmen Vigo may publish in the future.
Co-authorship network of co-authors of Carmen Vigo
This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Vigo. A scholar is included among the top collaborators of Carmen Vigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Vigo. Carmen Vigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 18 | |
| 3 | 7 | |
| 4 | 14 | |
| 5 | 19 | |
| 6 | 312 | |
| 7 | Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics. | 51 |
| 8 | Creutzfeldt-Jakob disease. Report of 10 neuropathologically-verified cases in Argentina | 1 |
| 9 | Orally active prostacyclin-mimetic RS-93427: therapeutic potential in vascular occlusive disease associated with atherosclerosis. | 5 |
| 10 | 59 | |
| 11 | 72 | |
| 12 | 48 | |
| 13 | 17 | |
| 14 | 33 | |
| 15 | 23 | |
| 16 | 5 | |
| 17 | 24 | |
| 18 | 79 | |
| 19 | Mechanism of action of anti-inflammatory steroids on membrane fluidity and phospholipase activity [proceedings]. | 2 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.